Saudi Pharmaceutical Industries and Medical Appliances Corporation
TADAWUL:2070.SR
32.8 (SAR) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) SAR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,653.084 | 1,426.337 | 1,459.784 | 1,559.477 | 1,552.515 | 1,274.819 | 1,386.042 | 1,841.194 | 1,705.051 | 1,470.186 | 1,296.623 | 1,244.905 | 1,129.218 | 1,037.641 | 950.741 | 871.939 | 797.748 | 727.838 |
| Cost of Revenue
| 945 | 860.016 | 839.918 | 867.659 | 1,001.765 | 654.418 | 681.581 | 931.814 | 872.948 | 675.649 | 595.1 | 564.589 | 568.649 | 551.42 | 532.367 | 510.657 | 472.514 | 419.421 |
| Gross Profit
| 708.084 | 566.322 | 619.866 | 691.818 | 550.75 | 620.402 | 704.461 | 909.381 | 832.103 | 794.537 | 701.523 | 680.316 | 560.569 | 486.221 | 418.374 | 361.282 | 325.234 | 308.417 |
| Gross Profit Ratio
| 0.428 | 0.397 | 0.425 | 0.444 | 0.355 | 0.487 | 0.508 | 0.494 | 0.488 | 0.54 | 0.541 | 0.546 | 0.496 | 0.469 | 0.44 | 0.414 | 0.408 | 0.424 |
| Reseach & Development Expenses
| 36.717 | 42.645 | 8.066 | 20.413 | 32.062 | 34.877 | 33.361 | 30.027 | 2.723 | 2.841 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 76.326 | 80.823 | 64.923 | 49.547 | 49.938 | 195.399 | 126.969 | 119.807 | 92.477 | 79.373 | 32.611 | 55.055 | 50.243 | 48.647 | 41.523 | 244.429 | 232.77 | 45.331 |
| Selling & Marketing Expenses
| 95.472 | 78.219 | 71.892 | 65.297 | 150.947 | 345.473 | 356.006 | 509.158 | 477.591 | 473.22 | 247.048 | 363.152 | 318.968 | 271.927 | 231.982 | 220.075 | 190.972 | 159.795 |
| SG&A
| 604 | 159.042 | 136.816 | 114.844 | 200.886 | 510.348 | 478.091 | 545.44 | 570.068 | 552.593 | 279.658 | 418.207 | 369.211 | 320.573 | 273.505 | 464.504 | 423.742 | 205.126 |
| Other Expenses
| -14.193 | 476.343 | 434.401 | 408.185 | 414.73 | 7.064 | -510.999 | 276.808 | 1.75 | 2.273 | 4.15 | 0 | 5.615 | 2.832 | -3.014 | 23.124 | 12.272 | 7.626 |
| Operating Expenses
| 645 | 678.03 | 579.282 | 543.442 | 647.678 | 538.161 | -510.999 | 276.808 | 570.068 | 552.593 | 492.371 | 418.207 | 374.827 | 323.405 | 270.491 | 487.628 | 436.014 | 212.752 |
| Operating Income
| 89.398 | -111.709 | 43.922 | 153.175 | -96.928 | 620.402 | 193.462 | 160.301 | 262.035 | 241.944 | 206.929 | 200.354 | 214.949 | 190.96 | 170.336 | -107.558 | -97.127 | 103.291 |
| Operating Income Ratio
| 0.054 | -0.078 | 0.03 | 0.098 | -0.062 | 0.487 | 0.14 | 0.087 | 0.154 | 0.165 | 0.16 | 0.161 | 0.19 | 0.184 | 0.179 | -0.123 | -0.122 | 0.142 |
| Total Other Income Expenses Net
| -53.214 | -20.876 | -21.773 | -33.245 | -154.7 | 28.538 | 56.737 | 165.314 | 114.065 | 97.419 | 79.77 | 50.843 | 23.591 | 25.131 | 24.249 | 0 | 0 | 0 |
| Income Before Tax
| 36.184 | -145.248 | 33.73 | 157.974 | -449.394 | 12.634 | 250.199 | 410.183 | 376.1 | 339.363 | 286.317 | 251.197 | 214.949 | 190.96 | 170.336 | -107.558 | -97.127 | 103.291 |
| Income Before Tax Ratio
| 0.022 | -0.102 | 0.023 | 0.101 | -0.289 | 0.01 | 0.181 | 0.223 | 0.221 | 0.231 | 0.221 | 0.202 | 0.19 | 0.184 | 0.179 | -0.123 | -0.122 | 0.142 |
| Income Tax Expense
| 45.26 | 24.983 | 12.346 | 43.897 | 31.678 | -90.195 | 52.834 | 33.491 | 19.046 | 22.51 | 110.272 | 80.319 | -31.306 | -9.103 | -3.907 | -271.713 | -244.916 | -11.112 |
| Net Income
| -13.711 | -170.232 | 26.454 | 124.787 | -481.072 | 102.829 | 197.366 | 376.692 | 357.054 | 316.853 | 266.821 | 232.633 | 211.433 | 176.525 | 154.804 | 128.269 | 121.864 | 99.15 |
| Net Income Ratio
| -0.008 | -0.119 | 0.018 | 0.08 | -0.31 | 0.081 | 0.142 | 0.205 | 0.209 | 0.216 | 0.206 | 0.187 | 0.187 | 0.17 | 0.163 | 0.147 | 0.153 | 0.136 |
| EPS
| -0.11 | -1.42 | 0.22 | 1.04 | -4.01 | 0.86 | 1.64 | 3.14 | 2.98 | 2.94 | 2.22 | 1.94 | 1.76 | 1.47 | 1.69 | 1.4 | 1.33 | 1.08 |
| EPS Diluted
| -0.11 | -1.42 | 0.22 | 1.04 | -4.01 | 0.86 | 1.64 | 3.14 | 2.98 | 2.94 | 2.22 | 1.94 | 1.76 | 1.47 | 1.69 | 1.4 | 1.33 | 1.08 |
| EBITDA
| 173.965 | -13.461 | 142.641 | 241.951 | -290.936 | 162.567 | 251.56 | 369.129 | 378.927 | 374.249 | 332.139 | 292.522 | 207.58 | 162.816 | 177.612 | -96.709 | -92.161 | 111.593 |
| EBITDA Ratio
| 0.105 | -0.009 | 0.09 | 0.177 | -0.136 | 0.032 | 0.191 | 0.237 | 0.292 | 0.233 | 0.253 | 0.228 | 0.179 | 0.154 | 0.19 | -0.131 | -0.131 | 0.143 |